Sold by: AdaptiveFlow Project
Open data
|
Deployed on AWS
AdaptiveFlow Versions of Ligand Libraries in Ready-To-Dock Format
Overview
AdaptiveFlow Versions of Ligand Libraries in Ready-To-Dock Format
Features and programs
Open Data Sponsorship Program
This dataset is part of the Open Data Sponsorship Program, an AWS program that covers the cost of storage for publicly available high-value cloud-optimized datasets.
Pricing
This is a publicly available data set. No subscription is required.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Open data resources
Available with or without an AWS account.
- How to use
- To access these resources, reference the Amazon Resource Name (ARN) using the AWS Command Line Interface (CLI). Learn more
- Description
- AdaptiveFlow Version of the Enamine REAL Space Molecule Library (version 2022q12) Containing 69 Billion Molecules in Ready-To-Dock Format.
- Resource type
- S3 bucket
- Amazon Resource Name (ARN)
- arn:aws:s3:::vf-libraries
- AWS region
- us-east-2
- AWS CLI access (No AWS account required)
- aws s3 ls --no-sign-request s3://vf-libraries/
Resources
Vendor resources
Support
Managed By
How to cite
AdaptiveFlow Ligand Libraries was accessed on DATE from https://registry.opendata.aws/vf-libraries .
License
There are no restrictions on the use of this data. Redistribution is not allowed without permission from Christoph Gorgulla. Keeping access credentials have to be kept confidential (each user gets their own access credentials).
Similar products
![Atinary SDLabs [Private Offer Only]](https://d7umqicpi7263.cloudfront.net/img/product/d0687cae-d3d6-4f2c-8b41-017b3183d89a.com/8b2fe104d9f191af2d34be53bc44d8eb)
Atinary SDLabs revolutionizes R&D with its no-code AI platform, accelerating the discovery of new materials for a healthier and more sustainable future. Scientists use SDLabs to optimize experimentation and uncover breakthrough materials from billions of molecular combinations - faster, smarter, and at a fraction of the cost.
Adaptive takes a unified approach to data security and infrastructure access management in a single platform helping organizations classify and protect sensitive data, govern access, and detect anomalies in real time.
AI-powered drug discovery pipeline on Amazon EKS, powered by NVIDIA BioNeMo NIM microservices—from protein sequence to ranked drug candidates.
The rapid advancement of computing technologies, particularly artificial intelligence (AI), has revolutionized various domains, including drug discovery. Curated datasets are crucial for developing reliable, generalizable, and accurate models for practical applications. Generating experimental data on a large scale is an expensive and arduous process. In domains such as medical diagnostics where real-life data is hard to obtain, synthetic data has been shown to be extremely valuable. We, teams from IIIT Hyderabad, Intel, AWS, and Insilico Medicine, have performed physics-based calculations (molecular dynamics simulations) on about 20,000 protein-ligand complexes. The dataset comprises molecular dynamics snapshots, binding affinities calculated using the MM-PBSA method, and individual energy components, including electrostatic and van der Waals interactions. DatasetFileFormats essentially incorporate i. 3D coordinates of the protein-ligand complexes (pdb) in tar.gz files, and ii. C[...]